Our Resources | Association for Accessible Medicines

COVID-19 and AAM - FAQ's and resources from the U.S. generics and biosimilars industry.

Jan 9, 2020 | Erica Klinger

Give IPR the Green Light

Nov 19, 2019 | Erica Klinger

USMCA: Nothing to See Here (Infographic)

Fix USMCA

May 6, 2019 | Erica Klinger

Anniversary of the May 10 Trade Amendments

Trade Agreement: 3 Obstacles to More Affordable Medicines in the U.S.

Mar 26, 2019 | Erica Klinger

NAFTA 2.0: Obstacles to More Affordable Medicines

Preserve Patient Access in USMCA

Nov 14, 2018 | Erica Klinger

Poll Results: USMCA Trade Agreement

New NAFTA - North American Generic Drugmakers Call for Rejection of New Exclusivity Period for Biologics

Sep 26, 2018 | Erica Klinger

Preserve Patient Access in NAFTA 2.0

Sep 21, 2018 | Erica Klinger

Lost Prescription Drug Savings in the U.S.

Sep 17, 2018 | Erica Klinger

Generic Drugs Are the Prescription for Savings. Here’s Why You Shouldn’t Take Them for Granted.

Prescription Drug Education - Opioid Abuse

Aug 16, 2018 | Erica Klinger

Prescription Drug Education Saves Lives and Dollars Infographic

Maryland statehouse in annapolis at sunset

Apr 13, 2018 | Erica Klinger

Protect Generic Rx Savings for Maryland Patients and Taxpayers

Skyrocketing Drug Prices Are a Threat to Everyone

Mar 26, 2018 | Erica Klinger

Skyrocketing Drug Prices Are a Threat to Everyone

Oct 30, 2017 | Erica Klinger

Spread of $100 Across Channels in Brand Drug Supply Chain